Forget NVIDIA. This is the New King of AI.

Business-focused summary (“AI cash machines” thesis)

The discussion argues that AI infrastructure spending is increasingly “just a cost” and that the next investor opportunity is the “application layer”: companies using AI to run real business workflows with measurable financial performance.

The host frames this as moving through waves: chips → software giants → infrastructure choke points → now application-layer “AI cash machines.”

Key “waves” framework mentioned

• Wave 1: Chips
• Wave 2: Software giants
• Wave 3: Choke points / physical buildout (e.g., memory, compute, power, grid)
• Wave 4: Application layer = AI running businesses (the “cash machines”)

Market/strategy framing (where money is going)

• Infrastructure is still being built fast, but “easy money is gone” because investors have already priced in much of the infrastructure upside.
• Wall Street “punishes” crowded positioning in infrastructure trades, with volatility driven by factors beyond pure fundamentals.

Infrastructure spending metrics cited

• Amazon + Microsoft + Google + Meta: ~$725B on AI infrastructure in 2026, +77% YoY
• Spending is expected to rise again in 2027
• “Trillion dollars on infrastructure” is characterized as capital cost until businesses monetize it.

Framework/playbook: “AI cash machines” segmentation by job-to-be-done

Keith Kaplan sorts target companies by the specific business function AI performs:

1. Deciders (AI replaces human decision-making)

   • Examples: underwriting/claims decisions, pricing, lending/insurance decisions.

2. Persuaders (AI optimizes advertising targeting/placement)

   • Example: ad selection/optimization at click-time.

3. Rebuilders (AI redesigns an old industry workflow)

   • Example: re-creating service delivery (e.g., therapy) via AI + software.

Extracted company picks (3 “cash machines”) with business signals & KPIs

1) Lemonade (Deciders) — AI insurer

Core claim: Lemonade operates like AI-driven software atop insurance infrastructure, enabling faster claims and improved unit economics.

Operational/business results & KPIs cited

• 3-second claims (AI process speed)
• Gross profit up ~10x with headcount barely moving
• ~$1M premium per employee
• 11 straight quarters of accelerating growth
• 166,000 new customers
• First profitable quarter, with profitability reaffirmed for year-end

Earnings/stock reaction

• Stock fell ~20% after earnings despite:
  • revenue beat
  • accelerated growth
  • profitability reaffirmed
• Explanation: the market wanted higher “raise” expectations, but Kaplan frames it as “opportunity” rather than machine failure.

Management/strategy timing

• CFO stepping down planned; new CFO begins beginning of 2027
• Kaplan expects continued execution because the model is already AI-driven.

Actionable recommendation (as stated)

• Potential buy/accumulate thesis: “buy because this company is going to keep doing what they do best.”

---

2) AppLovin (Persuaders) — AI media buyer / ad decision engine

Core claim: AppLovin’s AI engine (“Axon”) selects which ads hit users, optimizing outcomes with high profitability and “no factory/inventory” economics.

Operational/business results & KPIs cited

• Revenue up 59% (last quarter, per transcript)
• Net income ~ $1.2B–$2B (transcript appears inconsistent on the exact figure, but indicates very large profitability)
• ~65% net margin
• Market cap: ~$131B
• Institutional ownership: ~41% (noted as relatively low—suggesting Wall Street may be late)

Risk factor highlighted

• SEC investigation into data collection practices feeding its ad engine
• Kaplan’s stance: keep exposure sized modestly; expects resolution without business collapse (likely model changes rather than shutdown)

Earnings timing

• Earnings “coming up in a few days”
• Kaplan suggests:
  • watch earnings for surprises, or
  • view weakness as a potential entry (“flagship on sale”)

Actionable recommendation (as stated)

• Invest with modest sizing due to investigation risk; thesis remains profitability and AI ad targeting economics.

---

3) Hinge Health (Rebuilders) — AI physio/rehab platform

Core claim: Hinge Health rebuilds in-person physical therapy into an AI-guided, phone-camera-based continuous practice.

Operational/business results & KPIs cited

• Company size: ~$6B
• Revenue grew 47% last quarter
• Raised full-year outlook twice in 5 weeks
• Profitability noted (described as profitable)
• CFO credits AI efficiency for margins, not hiring (key operating lever)
• Market described as very large (Kaplan compares it to categories larger than diabetes/heart disease)

Business model/Go-to-market signals

• Partnerships with employers/companies that use it via what they pay out through health insurance
• Expansion thesis: once embedded, extend AI into other health verticals

Actionable recommendation

• Monitor earnings next week:
  • if blowout → stock may accelerate
  • if pullback → could be a “great entry”
• Expect ongoing implementation and scaling because AI delivery in healthcare is still new.

---

Cross-cutting themes and actionable investment logic

• Profitability matters: each “cash machine” is framed as already monetizing AI with strong margins/growth, not just “AI narratives.”
• Volatility isn’t dismissed:
  • Lemonade: pullback after beat due to expectations
  • AppLovin: volatility plus SEC headline risk
  • Hinge: pullbacks alongside broader AI market sentiment
• Risk management as a process:
  • “Invest small” and size exposure by risk tier
  • the report is framed as a menu, not a checklist

Explicit metrics summary (as mentioned)

• AI infrastructure spending
  • ~$725B (Amazon/Microsoft/Google/Meta) in the current year; +77% YoY
• Lemonade
  • 11 straight quarters accelerating growth
  • 166,000 new customers
  • gross profit ~10x
  • ~$1M premium/employee
  • first profitable quarter; profitability reaffirmed for end of year
• AppLovin
  • Revenue +59% (last quarter)
  • ~65% net margin
  • Net income ~ $1.2B–$2B (transcript inconsistent)
  • SEC investigation (data collection)
  • ~41% institutional ownership
• Hinge Health
  • Revenue +47% last quarter
  • Raised outlook twice in 5 weeks
  • Profitability
  • CFO attributes margins to AI efficiency

Presenters / sources

• Keith Kaplan, CEO of Trade Smith (primary source/analyst)
• Presenter/host: Bridget (only first name shown; no further identification provided)